Merit Medical Systems, Inc. $MMSI Shares Bought by UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC

UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC boosted its holdings in shares of Merit Medical Systems, Inc. (NASDAQ:MMSI) by 11.7% during the second quarter, HoldingsChannel.com reports. The firm owned 173,854 shares of the medical instruments supplier’s stock after purchasing an additional 18,276 shares during the period. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC’s holdings in Merit Medical Systems were worth $12,055,000 at the end of the most recent reporting period.

Several other institutional investors also recently bought and sold shares of MMSI. Los Angeles Capital Management LLC purchased a new stake in shares of Merit Medical Systems in the fourth quarter valued at approximately $25,000. Kilter Group LLC purchased a new position in shares of Merit Medical Systems during the 2nd quarter valued at approximately $25,000. Covestor Ltd grew its stake in Merit Medical Systems by 252.6% in the 4th quarter. Covestor Ltd now owns 469 shares of the medical instruments supplier’s stock valued at $41,000 after acquiring an additional 336 shares during the period. Danske Bank A S acquired a new stake in Merit Medical Systems in the 3rd quarter valued at $42,000. Finally, Quarry LP increased its holdings in Merit Medical Systems by 185.9% in the 3rd quarter. Quarry LP now owns 526 shares of the medical instruments supplier’s stock worth $44,000 after acquiring an additional 342 shares in the last quarter. 99.66% of the stock is owned by institutional investors and hedge funds.

Merit Medical Systems Price Performance

MMSI stock opened at $89.60 on Monday. The company has a market cap of $5.35 billion, a price-to-earnings ratio of 37.02, a PEG ratio of 2.24 and a beta of 0.49. The company has a current ratio of 4.20, a quick ratio of 2.79 and a debt-to-equity ratio of 0.44. Merit Medical Systems, Inc. has a 12 month low of $59.74 and a 12 month high of $94.75. The firm has a 50-day moving average of $81.85 and a two-hundred day moving average of $73.16.

Merit Medical Systems (NASDAQ:MMSI) last issued its earnings results on Thursday, July 30th. The medical instruments supplier reported $1.19 earnings per share for the quarter, topping the consensus estimate of $0.96 by $0.23. The business had revenue of $418.84 million for the quarter, compared to analysts’ expectations of $405.25 million. Merit Medical Systems had a return on equity of 13.75% and a net margin of 9.22%.The business’s revenue for the quarter was up 9.5% compared to the same quarter last year. During the same period in the previous year, the firm posted $1.01 EPS. Merit Medical Systems has set its FY 2026 guidance at 4.250-4.350 EPS. As a group, analysts forecast that Merit Medical Systems, Inc. will post 3.84 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

MMSI has been the subject of a number of research analyst reports. Piper Sandler upped their price objective on shares of Merit Medical Systems from $96.00 to $106.00 and gave the stock an “overweight” rating in a research report on Friday, July 31st. Weiss Ratings raised shares of Merit Medical Systems from a “hold (c-)” rating to a “hold (c)” rating in a research note on Tuesday, August 18th. Bank of America upped their price target on shares of Merit Medical Systems from $92.00 to $97.00 and gave the stock a “neutral” rating in a research report on Thursday, August 13th. JPMorgan Chase & Co. lifted their price objective on Merit Medical Systems from $77.00 to $95.00 and gave the stock an “overweight” rating in a report on Friday, July 31st. Finally, Zacks Research upgraded Merit Medical Systems from a “hold” rating to a “strong-buy” rating in a research note on Tuesday, August 25th. One analyst has rated the stock with a Strong Buy rating, eight have assigned a Buy rating and three have assigned a Hold rating to the company’s stock. According to data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average price target of $100.00.

Merit Medical Systems Profile

Merit Medical Systems, Inc is a global manufacturer and marketer of a broad range of medical devices used in diagnostic and interventional procedures. The company’s product portfolio encompasses vascular access, drainage, embolotherapy, and interventional oncology devices, as well as radiofrequency ablation systems and hemostasis solutions. These products serve physicians and hospitals in critical care settings and support minimally invasive treatment options across multiple specialties, including cardiology, radiology, oncology, neurology and endoscopy.

Founded in 1987 by Fred Lampropoulos, Merit Medical Systems has grown through both organic development and targeted acquisitions to expand its technology offerings and geographic reach.